📖

MAPT Haplotypes (H1/H2)

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-mapt-haplotypes

Related Entities

Metadata

slug	genes-mapt-haplotypes
entity_type	gene
kg_node_id	MAPTHAPLOTYPES

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (64)

mentions🧫Microtubule domain analysis in adult axons80%

mentions🧫Tau depletion effects on neuronal development in primary cul80%

mentions🧫Plasma ATN biomarkers across AD continuum in Chilean cohort80%

mentions🧫Tau depletion effects on neuronal development in primary cul80%

mentions🧫Creation and validation of 3xAD-ChAT-Cre mouse model80%

mentions🧫Double depletion rescue experiment: tau and MAP6 co-depletio80%

mentions🧫Tau depletion effects on microtubule domains in adult axons80%

related🧫Microtubule domain analysis in adult axons72%

related🧫Tau depletion effects on neuronal development in primary cul72%

related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort72%

related🧫Tau depletion effects on neuronal development in primary cul72%

related🧫Creation and validation of 3xAD-ChAT-Cre mouse model72%

related🧫Double depletion rescue experiment: tau and MAP6 co-depletio72%

related🧫Tau depletion effects on microtubule domains in adult axons72%

mentions🧫Differential GWAS of schizophrenia vs PTSD70%

mentions🧫GTEx brain tissue expression analysis of MAPT/CRHR1 locus70%

mentions🧫4R-Tau Targeting Therapies for PSP and CBS70%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%

mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%

mentions🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%

mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%

mentions🧫Tau ASO Therapy70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

related🧫Macroautophagy Dysfunction in PD - Experiment Design70%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers70%

related🧫Differential GWAS of schizophrenia vs PTSD63%

related🧫GTEx brain tissue expression analysis of MAPT/CRHR1 locus63%

related🧫4R-Tau Targeting Therapies for PSP and CBS63%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫CRISPR Gene Correction Approaches for CBS/PSP63%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%

related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers63%

related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%

related🧫Tau ASO Therapy63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones60%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction60%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy60%

mentions🧪Competitive APOE4 Domain Stabilization Peptides60%

see_also📖Neurodegeneration60%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

related🔬What are the mechanisms underlying apoe4 structural biology 50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT40%

mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise40%

mentions🧫Levodopa Response Determinants in PSP — Biomarker-Guided Pre40%

mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD40%

mentions🧫PSP and CBS Biomarker Validation Study40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%

related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%

related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%

related🧪Competitive APOE4 Domain Stabilization Peptides40%